University of North Carolina at Chapel Hill, J.D., high honors, 2014, Order of the Coif; North Carolina Law Review
George Mason University, B.S., high distinction, 1998
Sandra Wilburn assists clients in fund formations, private investment transactions and assorted intellectual property-related matters. She regularly works with fund managers to develop and execute fund offerings and advises institutional investors on private fund investments. She also assists corporate venture capital program clients with portfolio company investments.
Sandra counsels emerging company clients throughout their life cycles, from early stage formation-related issues through angel and venture financing rounds and exit events. In her intellectual property and licensing practice, Sandra assists life sciences, technology and health care clients in connection with software licensing, technology development and other intellectual property matters. She also provides general corporate assistance to a range of clients across industries and development stages.
Prior to joining Robinson Bradshaw, Sandra was an associate at K&L Gates. Before entering the legal field, she worked as a sales executive, providing technology consultation to pharmaceutical and biotechnology companies in areas such as DNA sequencing, laboratory robotics and analytic software across the research and clinical development spectrum. Sandra is admitted to practice before the U.S. Patent and Trademark Office.
Represents multiple companies in the defense, health care and technology industries in connection with their strategic venture capital investments in early-stage companies.
Represents institutional investors in connection with various investments, both domestic and foreign, in private investment funds of all types.
Represents private equity sponsor in raising over $150 million of capital commitments for multiple real estate-focused funds.
Represents a pooled investment fund manager in connection with the formation of multiple funds with aggregate capital commitments over $300 million.
Represents a large, regional health care system in the negotiation of numerous software licensing and consulting arrangements and other technology-related agreements.
Represents a national health care corporation in the negotiation and development of joint venture operations with hospitals and physician partners.
Assisted in due diligence review and analysis on behalf of an international public health care company for its $2 billion acquisition of a home dialysis equipment maker.
News & Events
- Oct. 10, 2016
- Jan. 16, 2019The Privacy Report Blog
- Dec. 17, 2018Triangle Funds Blog
- March 22, 2017American Health Lawyers Association
- North Carolina Bar Association
- Licensed to practice before the U.S. Patent and Trademark Office